| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |